Src promotes tumor cell invasion by hijacking the translation machineries

Read full text
Authors: Benjamin Bonnard, Anouk Chatefau, Cyril Dourthe, Sylvaine Di-Tommaso, Jean‐William Dupuy, Isabelle Mahouche, Jacobo Solórzano, Lea Fevrier, Morgane Le Bras, Anne-Aurelie Raymond, Violaine Moreau, Arnaud Jabouille
+3 more Anne Blangy, Yvan Martineau, Frédéric Saltel
Cited by: 1
References: 61

Abstract

The Src oncogene controls cancer cell invasiveness by promoting invadosome formation and extracellular matrix (ECM) degradation. Invadosomes are translational hotspots enriched in the eukaryotic translation initiation factor 3 (eIF3) complex that is mandatory for their maintenance. Here, we determined that Src regulates mRNA translation and controls the expression of eIF3 subunits, including eIF3h, eIF3e, and eIF3d. These subunits are crucial for invadosome formation and ECM degradation. Src also modulates both canonical eIF4E-dependent translation via the activation of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway and the non-canonical translation mechanism through eIF3d overexpression, both of which are necessary for invadosome function. Moreover, overexpression of Src and eIF3h/e/d correlates with poor prognosis in patients with hepatocellular carcinoma (HCC), promoting ECM degradation and tumor invasiveness of HCC cells. This study identifies Src as a major regulator of translation initiation, modulating invadosome formation, ECM degradation, and tumor cell invasion.

Fields of Study & Subjects

Cell Adhesion Molecules Research RNA and protein synthesis mechanisms Wnt/β-catenin signaling in development and cancer

Publication details

Journal / source
Cell Reports
Publisher
Elsevier BV
Volume
45
Issue
3
Pages
116989–116989
Publication date
23 February 2026
Language
EN